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Abstract
Background: Deficits in gait and balance are common among neurological inpatients. Currently, assessment of
these patients is mainly subjective. New assessment options using wearables may provide complementary and
more objective information.
Methods: In this prospective cross-sectional feasibility study performed over a four-month period, all patients
referred to a normal neurology ward of a university hospital and aged between 40 and 89 years were asked
to participate. Gait and balance deficits were assessed with wearables at the ankles and the lower back.
Frailty, sarcopenia, Parkinsonism, depression, quality of life, fall history, fear of falling, physical activity, and
cognition were evaluated with questionnaires and surveys.
Results: Eighty-two percent (n = 384) of all eligible patients participated. Of those, 39% (n = 151) had no gait
and balance deficit, 21% (n = 79) had gait deficits, 11% (n = 44) had balance deficits and 29% (n = 110) had
gait and balance deficits. Parkinson’s disease, stroke, epilepsy, pain syndromes, and multiple sclerosis were the
most common diseases. The assessment was well accepted.
Conclusions: Our study suggests that the use of wearables for the assessment of gait and balance features
in a clinical setting is feasible. Moreover, preliminary results confirm previous epidemiological data about gait
and balance deficits among neurological inpatients. Evaluation of neurological inpatients with novel wearable
technology opens new opportunities for the assessment of predictive, progression and treatment response
markers.
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Background
Gait and balance deficits occur in many neurological dis-
eases. The evaluation of these deficits at the wards of hos-
pitals is often based on qualitative parameters collected by
the treating physicians and allied health professionals or on
semi-quantitative scoring tools. For example, in Parkinson’s
disease (PD), the Unified Parkinson Disease Rating Scale
(MDS-UPDRS) is regularly used to rate motor symptoms
including gait and postural stability [1]. While such scales,
questionnaires and surveys have been subject to multiple
validation studies, they have limitations regarding
inter-rater variability and subjectivity [2–5].
With the recent and ongoing development of wear-
ables (mainly in the sport and fitness sectors), this tech-
nology has reached a sophisticated level making it
interesting for medical purposes [6–16]. A particularly
relevant field is the complementary assessment of inpa-
tients at neurological wards, as wearables are specifically
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capable of assessing gait and balance deficits which are
common in neurological patients [15, 17].
Only a small number of studies have investigated feasi-
bility and acceptability of wearables in an inpatient set-
ting, with limitations such as small sample sizes [18] and
the investigation of only one disease [19]. This study
aims to investigate the feasibility and usefulness of wear-
ables during clinical evaluation in a large sample of
neurological inpatients.
Methods
Participants
All inpatients referred to the three normal wards of the
Neurology Center at the University Hospital of Tübingen
between 09/2014 and 04/2015 (16-week assessment
periods for each ward) were asked to take part in the study
if they were between 40 to 89 years of age (this selection
criterion was chosen due to feasibility issues) and were
able to walk with or without walking aid. Exclusion cri-
teria were the inability to give informed consent, a fall fre-
quency of more than one fall per week (risk of falls during
the assessment too high), and impaired cognition as de-
fined by a Mini Mental State Examination (MMSE) score
below 10 points. Participants who had at least one fall dur-
ing the last 2 years were defined as fallers. The ethics com-
mittee of the medical faculty of the University of
Tübingen approved the study (No. 356/2014BO2) and all
participants gave written informed consent prior to
participation.
Quantitative gait and balance assessment
Participants were equipped with a wearable sensor
system (Rehawatch®, Hasomed, Magdeburg, Germany)
consisting of three sensor-units worn at both ankles
and at the lower back (L4-L5) [20]. Each sensor-unit
contains 3D accelerometers (±8 g), 3D gyroscopes
(±2000°/s) and 3D magnetometers (±1.3Gs) resulting
in nine degrees of freedom and the raw data was
processed and analyzed using validated and company
provided algorithms [21]. The assessment included
the following tasks: Participants walked seven times a
20 m distance under single (slow, comfortable, and
fast speed) and dual tasking conditions (checking
boxes and subtracting serial 7 s during comfortable
and fast walking) [22, 23]. Static balance during quiet
standing at the center of stability was tested on flat
ground with four different positions of the feet for
30 s each: open stance with feet placed in parallel
position with 5–10 cm in between, closed stance (par-
allel position), semi-tandem stance, and tandem
stance [24]. The task one difficulty level below the
one successfully performed on flat ground was then
performed for 30 s on a foam pad (Airex balance
pad, 50x41x6 cm). Static balance at the limit of
stability was tested with an adapted version of the
Functional Reach Test [25] over a 15 s period. Overall
mobility and transfer was tested with the
Timed-Up-and-Go test (TUG) under comfortable and
fast speed conditions [26–28]. Muscle strength was
assessed with a hydraulic hand dynamometer (DanMic
Global®, San Jose, USA) and muscle mass with bioim-
pedance (Akern Bia 101, SMT medical GmbH&Co.
KG, Würzburg, Germany).
Assessments with scales and questionnaires
Fear of falling was assessed with the German version of
the Falls Efficacy Scale-International (FES-I) [29].
Self-concepts of health, activity, cognition, social support
and risk factors for age-associated diseases were assessed
[30]. Depression was evaluated with the German version
of the Beck’s Depression Inventory II (BDI-II) [31, 32].
Health-related quality of life was assessed with the
EQ-5D-5 L. This scale addresses mobility, autonomy,
pain, fear, despondence, daily living activities and health
[33]. The MMSE [34] and the Trail Making Test (TMT)
[35] were used to assess cognition, and part III of the
Movement Disorders Society-sponsored Unified Parkin-
son’s Rating Scale (MDS-UPDRS) [1] was used for the
assessment of motor symptoms. Function of the sensory
nerves was assessed at the medial malleoli of the lower
extremities and the basal joint of each thumb with a
Rydel Seiffer tuning fork.
Classification of impaired gait and balance
A gait deficit was defined as > 15% lower walking
speed compared to mean age-corrected speed accord-
ing to [36, 37]. Presence of a balance deficit was con-
sidered when tandem stance could be performed no
longer than 10 s [38, 39].
Statistical analysis
Statistical analysis was conducted with JMP 11.1.1
(SAS). Demographic data of the different groups were
compared with Kruskal-Wallis-test (or Fisher’s exact test
for categorical data). Post hoc testing was performed
with Mann-Whitney-U test. P values below 0.05 were
considered significant. Bonferroni correction for mul-
tiple testing was applied for post-hoc tests (p < 0.0083).
Results
Of 468 inpatients eligible for the study (i.e., fulfilled all
inclusion criteria and no exclusion criterion, and were
not excluded due to logistic reasons), 384 (82%) partici-
pated. Of those, 60% were male. Mean age of the cohort
was 62 years. The 10 most common diagnoses (69% of
all investigated patients) were Parkinson’s disease (PD, n
= 51), stroke (n = 50), epilepsy (n = 30), pain syndromes
(n = 26), multiple sclerosis (MS, n = 23), CNS tumours
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(n = 19), polyneuropathy (n = 18), vertigo (n = 16), de-
mentia (n = 16), and meningitis/encephalitis (n = 15).
During the study, no severe adverse events occurred
(Fig. 1).
One hundred and 51 participants (39%) had no gait
and balance deficit (control group), 79 (21%) had a gait
deficit, 44 (11%) had a balance deficit and 110 (29%) had
a gait and balance deficit. The highest proportion of pa-
tients with gait deficits (33%) was found in the
meningitis/encephalitis cohort, the highest proportion of
patients with balance deficits (17%) in the MS cohort,
and the highest proportion of participants with gait and
balance deficits (41%) in the PD cohort. Patients with
pain syndromes had rarely gait and/or balance deficits.
Patients complied well with the quantitative gait
and balance assessment and descriptive results from
the balance, gait and postural transitions are shown
in Figs. 2, 3 and 4.
Fig. 1 Graphical representation of the ten most common diagnoses within the 384 study participants
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Fig. 2 During the balance assessment the participants with a balance or gait and balance deficit show the largest sway area compared to the
controls and the patients with the gait deficit
Bernhard et al. BMC Neurology  (2018) 18:114 Page 3 of 8
Fig. 3 During the gait assessments (single and dual task conditions) the participants with a gait or gait and balance deficit show the largest
number of steps, the smallest stride length and the highest stride duration compared to the controls and the participants with a balance deficit
Fig. 4 The TUG tests shows a similar pattern and the duration of the individual phases is increased for participants with a gait or gait and
balance deficit compared to the controls and the participants with a balance deficit
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MMSE and TMT performances were significantly
worse in all cohorts with gait and/or balance deficits,
compared to the control cohort. Moreover, the cohort
with gait and balance deficits performed worse in the
TMT compared to the group with gait deficits. TUG
durations were slower in the cohort with gait and
balance deficits than in both the gait deficit cohort
and the balance deficit cohort, and fastest in the con-
trol cohort. The same pattern was observed with re-
gard to fear of falling, with highest FES-I values (i.e.
the highest fear of falling) in the gait and balance def-
icits cohort. BDI II values were higher in the cohort
with gait and balance deficits, compared to the con-
trol cohort. The cohort with gait and balance deficits
had lower grip force when compared to the cohort
with gait deficits and the control cohort. A more de-
tailed description of the inter-cohort comparisons is
presented in Table 1.
Discussion
In the presented study, we performed routine clinical
gait and balance assessments complemented by an ex-
haustive evaluation of geriatric parameters in a neuro-
logical department at a university hospital. To the
best of our knowledge, this is the first sensor-based
cross-sectional study in a clinical environment of a
university hospital, covering a wide range of neuro-
logical diseases. Our overall cohort represents a wide
range and representative number of neurological dis-
eases. A study with a similar setting but without
sensor-unit-based assessments displayed a comparable
composition of neurological diseases [17] with the five
most common diagnoses completely overlapping.
Acceptance of sensor-unit-based assessments in our
study was high. Only 18% of eligible patients refused to
take part in the study. We did not experience any logis-
tical issues during the assessments. The sensor system
Table 1 Demographic, clinical, and semiquantitative/quantitative study outcomes of the whole cohort, as well as of the subcohorts
with and without gait and balance deficits
Whole cohort
(N = 384)
Controls
(N = 151)
Gait deficits
(N = 79)
Balance deficits
(N = 44)
Gait and balance deficits
(N = 110)
P-Value
Median Range Median Range Median Range Median Range Median Range
Age [years] 64 40–90 57 40–86 60 40–89 70*# 44–89 69.5*# 41–90 < 0.0001
Gender [% female] 42.4 43.0 36.7 43.2 45.5 0.67
Height [m] 1.72 1.48–2.01 1.73 1.49–2.01 1.73 1.48–1.98 1.70 1.58–1.88 1.70 1.49–2.00 0.04
Weight [kg] 79 37–134 80 50–134 82 46–117 79 55–115 74 37–123 0.13
BMI [kg/m2] 26.2 14.9–43.0 26.3 19.4–41.8 26.4 17.3–41.6 26.8 19.4–38.4 25.9 14.9–43.0 0.77
Falls in the last 24
months [N]
0 0–100 0 0–50 0 0–50 1* 0–55 1*# 0–100 < 0.0001
At least one fall in the last
24 months [%]
46 29 42 62* 65*# < 0.0001
LACHS (0–15) 3 0–10 2 0–8 3* 0–6 3* 1–9 4*# 0–10 < 0.0001
MMSE (0–30) 28 13–30 29 24–30 28* 13–30 28* 13–30 27* 13–30 < 0.0001
TMT-A [s] 49 13–300 38 13–300 48* 23–300 55* 26–300 72*# 17.7–300 < 0.0001
TMT-B [s] 149 34–300 101 34–300 129* 38–300 174* 60–300 300*# 38.8–300 < 0.0001
ΔTMT [s] 85 −30-280 60 −30-280 78* 0–253 98 0–257 149* 0–270 < 0.0001
Timed up and go
convenient speed [s]
12 6–92 10 6–25 12* 8–28 11* 8–18 16*#+ 8–92 < 0.0001
Timed up and go fast
speed [s]
9 5–47 7 5–15 10* 6–22 11* 6–15 14*#+ 7–47 < 0.0001
BDI II (0–63) 10 0–51 8 0–51 10 0–28 10 0–38 12* 0–51 0.0004
FES-I (0–64) 20 0–64 18 0–63 21* 0–44 20* 14–48 27*#+ 14–64 < 0.0001
EQ5D VAS (0–100) 60 1–100 70 20–100 55 10–95 50* 5–90 50*# 1–95 < 0.0001
Functional Reach [cm] 23 3–82 27 8–45 23* 3–82 20* 5–35 18*# 5–34 < 0.0001
Gait speed [m/s] 1.10 0.27–2.33 1.34 0.95–2.33 0.99* 0.56–1.67 1.15*# 0.81–2.03 0.80*#+ 0.27–1.5 < 0.0001
Grip force [kg] 27 3–76 29 10–76 29 7–56 28 15–51 23*# 3–51 < 0.0001
Data is presented with median and range. P-values were calculated using the Kruskal-Wallis-test, with post hoc Mann-Whitney-U-Test and Chi2 test. For post hoc
testing Bonferroni correction for multiple testing was applied. * p < 0.0083 for comparison with the control cohort group, #p < 0.0083 for comparison with the gait
deficit cohort, +p < 0.0083 for comparison with the balance deficit cohort. BDI II Beck’s depression inventory II, BMI Body mass index, EQ5D VAS Visual analog scale
of the EuroQol-5 dimension questionnaire, FES-I Falls efficacy scale international, LACHS Geriatric screening according to Lachs et al., MMSE Mini-mental state
examination, TMT Trail making test (part A, B, and B-A = ΔTMT)
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was easy and quick to apply and none of the patients
felt restricted by the sensor system. Moreover, no ser-
ious adverse events, e.g. falls, occurred. These results
bode well for the clinical uptake of wearable sensors
into regular care.
Not surprisingly, frequencies of gait and balance defi-
cits of neurological inpatients are higher compared to
observations in the community and in outpatient clinics.
However, these deficits are ubiquitously observed. In a
community-based study investigating 467 participants,
the prevalence of gait deficits was 14% in those between
67 and 74 years of age, 29% in those between 75 and
84 years and 49% in those 85 years and older [40]. In a
cross-sectional investigation of 488 community residing
adults aged between 60 and 97 years, 32% of the cohort
presented with impaired gait and the prevalence in-
creased with age. However, 38% of the subjects aged
80 years and older still had a normally preserved gait
[41]. In outpatients clinics, gait deficits occur in 35% of
patients, most of them having neurological causes [42].
It is of note that, in our study, the cohort with gait
(but not balance) deficits was of similar age as the con-
trol cohort. This suggests that the slower gait speed of
this group was not induced by an overall decline in per-
formance due to aging, but rather due to the underlying
disease processes. This could be an interesting observa-
tion in the light of ongoing studies investigating gait
speed as a relevant outcome parameter for disease and
disability. Moreover, groups with gait and/or balance
deficits showed impaired cognitive performance com-
pared to the control group, supporting the association
between motor performance and cognition [43–45]. It is
also of note that not only the balance deficit cohort but
also the gait deficit cohort performed worse than the
controls in the functional reach test. This finding sup-
ports the link between static balance and gait and
reflects the various aspects of postural control which
should be further investigated in future studies.
The current study has several limitations. First, only
gait velocity was used to define gait deficits. Although
reduced gait speed impacts patients’ mobility, there
are several additional gait variables (e.g. gait variabi-
lity, asymmetry) which are important features as they
are associated with fall risk [46–49]. However, nume-
rous more sophisticated algorithms are currently de-
veloped and validated allowing investigation of the
multidimensional aspects of postural control (e.g.,
[20, 50, 51]) in more detail. Including dynamic, pro-
active, and reactive postural control parameters will
give a broader view of the multidimensional aspects
of balance control and help understand different
pathologies of the diseases. This aspect is currently
the focus of a more detailed sensor-unit-based ana-
lysis of the dataset.
Conclusion
In conclusion, this study shows that the use of inertial sensors
in a clinical setting by investigating patients in neurological
wards of a university hospital over a time of 16 weeks is feas-
ible. These results should motivate to further design inpatient
assessments using wearable technology, and of collaborative
projects using such datasets for further in-depth analyses.
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